These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention]. Brovkina AF; Zarubeí GD; Val'skií VV Vestn Oftalmol; 1997; 113(3):14-6. PubMed ID: 9265351 [TBL] [Abstract][Full Text] [Related]
5. [Report on 50 cases of uveal melanoma treated by conservative beta curietherapy]. Grange JD; Bonnet M; Bievelez B; Jean-Louis B; Quintero P; Santamaria E; Guillaubey Y; Gérard JP; Delaroche G; Mere P Bull Soc Ophtalmol Fr; 1987 Nov; 87(11):1297-300. PubMed ID: 3451841 [No Abstract] [Full Text] [Related]
6. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: evaluation of 175 patients treated with 150 Gy from 1981-1989. Pötter R; Janssen K; Prott FJ; Widder J; Haverkamp U; Busse H; Müller RP Front Radiat Ther Oncol; 1997; 30():143-9. PubMed ID: 9205894 [No Abstract] [Full Text] [Related]
7. The treatment of ciliary body melanoma by beta radiation. Foerster MH; Wessing A; Meyer-Schwickerath G Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():64-7. PubMed ID: 6581638 [No Abstract] [Full Text] [Related]
8. [Beta-Curie contact therapy in the conservative treatment of uveal melanoma. Evaluation of the first 100 cases treated]. Grange JD Bull Soc Belge Ophtalmol; 1988; 229():15-21. PubMed ID: 3273250 [No Abstract] [Full Text] [Related]
12. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063 [TBL] [Abstract][Full Text] [Related]
13. Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy. Muen WJ; Damato BE Eye (Lond); 2007 Feb; 21(2):307-8. PubMed ID: 16946742 [No Abstract] [Full Text] [Related]
14. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques. Puusaari I; Heikkonen J; Kivelä T Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045 [TBL] [Abstract][Full Text] [Related]
15. [Bilateral uveal melanoma: a case report]. Dunavoelgyi R; Dejaco-Ruhswurm I; Streubel B; Zehetmayer M Klin Monbl Augenheilkd; 2007 Nov; 224(11):858-61. PubMed ID: 18034402 [TBL] [Abstract][Full Text] [Related]
16. Pigmented episcleral deposits after brachytherapy of uveal melanoma. Toivonen P; Kivelä T Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837 [TBL] [Abstract][Full Text] [Related]
18. [The analysis of I125 brachytherapy complications in cases of uveal melanoma]. Pogrzebielski A; Starzycka M; Romanowska-Dixon B; Jakubowska B; Szpakowicz U Klin Oczna; 2005; 107(1-3):49-53. PubMed ID: 16052800 [TBL] [Abstract][Full Text] [Related]
19. Early macular morphological changes following plaque radiotherapy for uveal melanoma. Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; Shields JA Retina; 2008 Feb; 28(2):263-73. PubMed ID: 18301032 [TBL] [Abstract][Full Text] [Related]
20. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis. Frenkel S; Hendler K; Pe'er J Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]